Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersCardiovascular Disease Physician in Torrance, CA
NPI: 1316957228Primary Practice Location
LAC/HARBOR-UCLA MED CENTER
1000 W Carson St, Torrance, CA
Primary Employer
Harbor - UCLA Medical Center
dhs.lacounty.gov
HQ Phone
Get M.D. Ronald's Phone Numberphone_androidMobile
Get M.D. Ronald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1990 - 2026
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Cardiovascular Disease
Los Angeles County-Harbor-UCLA Medical Center
Fellowship • Cardiovascular Disease
1992 - 1995
University of California (San Diego) Medical Center
Internship • Internal Medicine
1989 - 1990
Keck School of Medicine of USC
keck.usc.edu
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94618Test for exercise-induced lung stress | 20 | 28 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 17 | 32 |
Authors: Jeffrey Wilt, Robert Simms, Christopher Barnett, Russel Hirsch, Murali Chakinala, Nitin Bhatt, David Ivy, Ghulam Saydain, Adaani Frost, Charles Burger, Thenappan Thenappan, Jean Elwing, Delphine Yung, Raymond Benza, Sahil Bakshi, Nicholas Hill, Erika Berman - Rosenzweig, Robert Walter, Rahul Argula, Terry Fortin, Eric Austin, Marc Simon, Ankit Desai, Amit Arora, Ivan Robbins
Publication Date: 2018-12-05
End Points and Clinical Trial Designs in Pulmonary Arterial Hypertension Clinical
Authors: Marius M. Hoeper, Ronald J. Oudiz, Andrew J. Peacock, Victor F. Tapson, Sheila
Publication Date: 2004-06
'Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With
Authors: Sarathy Mandayam
Publication Date: 1997-08
Lead Sponsor: United Therapeutics
Intervention / Treatment: DRUG: Intravenous/Subcutaneous Treprostinil; Oral Treprostinil
Lead Sponsor: Gmax Biopharm LLC.
Intervention / Treatment: DRUG: Q4W GMA301 IV injections (300 mg), DRUG: Q4W GMA301 IV injections (600 mg), DRUG: Q4W GMA301 IV injections (1000 mg), DRUG: Q4W GMA301 IV injections (1800 mg), OTHER: Q4W placebo IV injections
Lead Sponsor: United Therapeutics
Intervention / Treatment: DRUG: Placebo, DRUG: Ralinepag
